E
Valeo Pharma Inc.
VPHIF
$0.0469
-$0.0471-50.11%
E
Sell
3/21/2024Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 3/21/2024 due to a decline in the solvency index and volatility index. The quick ratio declined from 0.69 to 0.29, and debt to equity increased from -1.63 to -1.37.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 3/21/2024 due to a decline in the solvency index and volatility index. The quick ratio declined from 0.69 to 0.29, and debt to equity increased from -1.63 to -1.37.
D
Sell
3/12/2024Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 3/12/2024 due to an increase in the total return index and volatility index.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 3/12/2024 due to an increase in the total return index and volatility index.
E
Sell
2/26/2024Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 2/26/2024 due to a decline in the volatility index.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 2/26/2024 due to a decline in the volatility index.
D
Sell
2/9/2024Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 2/9/2024 due to an increase in the volatility index.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 2/9/2024 due to an increase in the volatility index.
E
Sell
10/5/2023Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 10/5/2023 due to a decline in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 10/5/2023 due to a decline in the volatility index and total return index.
D
Sell
9/19/2023Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 9/19/2023 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0571 to -$0.0518, and total revenue increased 5.45% from $10.01M to $10.56M.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 9/19/2023 due to a noticeable increase in the growth index and volatility index. Earnings per share increased from -$0.0571 to -$0.0518, and total revenue increased 5.45% from $10.01M to $10.56M.
E
Sell
8/30/2023Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 8/30/2023 due to a decline in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 8/30/2023 due to a decline in the volatility index and total return index.
D
Sell
8/14/2023Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 8/14/2023 due to an increase in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 8/14/2023 due to an increase in the volatility index and total return index.
E
Sell
7/26/2023Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 7/26/2023 due to a decline in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 7/26/2023 due to a decline in the volatility index and total return index.
D
Sell
7/7/2023Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 7/7/2023 due to an increase in the volatility index.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 7/7/2023 due to an increase in the volatility index.
E
Sell
6/20/2023Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 6/20/2023 due to a decline in the volatility index and growth index.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 6/20/2023 due to a decline in the volatility index and growth index.
D
Sell
6/15/2023Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 6/15/2023 due to an increase in the total return index and volatility index.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 6/15/2023 due to an increase in the total return index and volatility index.
E
Sell
5/24/2023Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 5/24/2023 due to a decline in the total return index and volatility index.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 5/24/2023 due to a decline in the total return index and volatility index.
D
Sell
5/9/2023Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 5/9/2023 due to an increase in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 5/9/2023 due to an increase in the volatility index and total return index.
E
Sell
4/21/2023Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 4/21/2023 due to a decline in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 4/21/2023 due to a decline in the volatility index and total return index.
D
Sell
4/3/2023Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 4/3/2023 due to an increase in the volatility index.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 4/3/2023 due to an increase in the volatility index.
E
Sell
3/16/2023Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 3/16/2023 due to a decline in the volatility index and solvency index. Debt to equity increased from -3.46 to -2.54, and the quick ratio declined from 1.82 to 1.47.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 3/16/2023 due to a decline in the volatility index and solvency index. Debt to equity increased from -3.46 to -2.54, and the quick ratio declined from 1.82 to 1.47.
D
Sell
3/14/2023Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index and volatility index.
D
Sell
2/9/2023Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was upgraded to D from E+ on 2/9/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D on 02/08/2023.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D on 02/08/2023.
D
Sell
12/16/2022Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 12/16/2022 due to an increase in the total return index and volatility index.
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 12/16/2022 due to an increase in the total return index and volatility index.
D
Sell
11/21/2022Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 11/21/2022 due to a decline in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 11/21/2022 due to a decline in the volatility index and total return index.
D
Sell
11/4/2022Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 11/4/2022 due to an increase in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 11/4/2022 due to an increase in the volatility index and total return index.
D
Sell
10/20/2022Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 10/20/2022 due to a decline in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 10/20/2022 due to a decline in the volatility index and total return index.
D
Sell
10/5/2022Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 10/5/2022 due to an increase in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 10/5/2022 due to an increase in the volatility index and total return index.
D
Sell
9/15/2022Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 9/15/2022 due to a decline in the volatility index and total return index.
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 9/15/2022 due to a decline in the volatility index and total return index.
D
Sell
7/21/2022Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 7/21/2022 due to an increase in the volatility index.
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 7/21/2022 due to an increase in the volatility index.
D
Sell
7/6/2022Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 7/6/2022 due to a decline in the volatility index and valuation index.
Valeo Pharma Inc. (VPHIF) was downgraded to D- from D on 7/6/2022 due to a decline in the volatility index and valuation index.
D
Sell
6/15/2022Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 6/15/2022 due to an increase in the valuation index and volatility index.
Valeo Pharma Inc. (VPHIF) was upgraded to D from D- on 6/15/2022 due to an increase in the valuation index and volatility index.
D
Sell
5/5/2022Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 5/5/2022 due to an increase in the valuation index.
E
Sell
4/20/2022Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 4/20/2022 due to a decline in the valuation index, solvency index and volatility index. Debt to equity increased from 3.12 to 35.95.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 4/20/2022 due to a decline in the valuation index, solvency index and volatility index. Debt to equity increased from 3.12 to 35.95.
D
Sell
11/23/2021Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index and valuation index.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 11/23/2021 due to an increase in the total return index and valuation index.
E
Sell
11/8/2021Downgrade
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 11/8/2021 due to a major decline in the volatility index, total return index and solvency index.
Valeo Pharma Inc. (VPHIF) was downgraded to E+ from D- on 11/8/2021 due to a major decline in the volatility index, total return index and solvency index.
D
Sell
6/1/2021Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 06/01/2021.
Valeo Pharma Inc. (VPHIF) was upgraded to D- from E+ on 06/01/2021.
E
Sell
3/1/2021Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to E+ from E on 03/01/2021.
Valeo Pharma Inc. (VPHIF) was upgraded to E+ from E on 03/01/2021.
E
Sell
2/26/2021Upgraded
Valeo Pharma Inc. (VPHIF) was upgraded to E from E- on 2/26/2021 due to a significant increase in the solvency index, growth index and total return index. The quick ratio increased from 0.19 to 0.95, total revenue increased 53.63% from $1.09M to $1.68M, and earnings per share increased from -$0.0208 to -$0.0145.
Valeo Pharma Inc. (VPHIF) was upgraded to E from E- on 2/26/2021 due to a significant increase in the solvency index, growth index and total return index. The quick ratio increased from 0.19 to 0.95, total revenue increased 53.63% from $1.09M to $1.68M, and earnings per share increased from -$0.0208 to -$0.0145.
E
Sell
12/16/2020None
Valeo Pharma Inc. (VPHIF) was downgraded to E- from U on 12/16/2020.
Valeo Pharma Inc. (VPHIF) was downgraded to E- from U on 12/16/2020.
OTC PK
08/29/2024 10:03AM Eastern
Quotes delayed
